Pfizer and BioNTech launch trial of Omicron-targeted Covid vaccine

Re:Pfizer and BioNTech launch trial of Omicron-targeted Covi... by walterbell on Tuesday January 25, 2022 @03:26PM (#30077569)

Yes, we need more transparency on all the trials, e.g. comparing methodology and benchmarking against standard practices. Justifications for corner cutting in 2020 trials should not apply to 2022+ trials. If this issue were more widely understood, there would be several open-source repos aggregating "lessons learned" and public info about the trials, across countries and vendors.

[ Parent | on HN ]

Re:Pfizer and BioNTech launch trial of Omicron-targeted Covi... by loceng on Tuesday January 25, 2022 @07:14PM (#30080020)

It's interesting that you're minimizing the gross lack of integrity as simply corner cutting - there isn't a single valid reason for that. Anything counter-mainstream narrative is suppressed, so that is part of the problem to your "if this issue were more widely understood" - the scientific process, conversation, has been highly suppressed over these last 2 years.

A major British medical journal just demanded that the raw trial data be released - but will it even be untampered with - like the Maddie De Garay situation insinuates happens widespread since there were no, and still no, government health agencies who have sounded an alarm - or caught it and put a hold on the vaccine release for different age groups until uncompromised trials were completed?

The system capture here is so obvious it's blinding.

[ Parent | on HN ]

Re:Pfizer and BioNTech launch trial of Omicron-targeted Covi... by walterbell on Tuesday January 25, 2022 @10:15PM (#30081226)

Step 1 is to remove plausible deniability, e.g. urgency being used to bypass existing controls, and restore some systemic control. Ultimately we will need new systems to prevent this from happening again, at many levels of governance.

There are many nested challenges, e.g. system/regulatory capture is not new, but can you think of a single historical example with pervasive lockstep censorship across media, industry and government in multiple countries? Did government relief/stimulus funding distort incentives for health outcomes, e.g. ineffective high-fee ventilators vs. early treatment with existing drugs?

Even in the face of lockstep censorship, as truth/facts surfaced in 2020-2021, why did no organized presentation achieve widespread public visibility? Without an accurate threat model (e.g. infiltration of health freedom groups, https://ccsfreedom.org/), truth will not be sufficient to prevail against organized opposition.

[ Parent | on HN ]